ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00940225
Recruitment Status : Completed
First Posted : July 15, 2009
Last Update Posted : February 19, 2015
Sponsor:
Information provided by (Responsible Party):
Exelixis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2013
  Actual Study Completion Date : June 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):